These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 7750111)

  • 1. Recurrent cytogenetic aberrations in human ovarian carcinomas.
    Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A
    Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent cytogenetic aberrations and loss of constitutional heterozygosity in ovarian carcinomas.
    Kiechle-Schwarz M; Bauknecht T; Karck U; Kommoss F; du Bois A; Pfleiderer A
    Gynecol Oncol; 1994 Nov; 55(2):198-205. PubMed ID: 7959284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome aberrations in 35 primary ovarian carcinomas.
    Pejovic T; Heim S; Mandahl N; Baldetorp B; Elmfors B; Flodérus UM; Furgyik S; Helm G; Himmelmann A; Willén H
    Genes Chromosomes Cancer; 1992 Jan; 4(1):58-68. PubMed ID: 1377010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
    Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms.
    Mertens F; Johansson B; Höglund M; Mitelman F
    Cancer Res; 1997 Jul; 57(13):2765-80. PubMed ID: 9205089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse painting of microdissected chromosome 19 markers in ovarian carcinoma identifies a complex rearrangement map.
    Micci F; Weimer J; Haugom L; Skotheim RI; Grunewald R; Abeler VM; Silins I; Lothe RA; Trope CG; Arnold N; Heim S
    Genes Chromosomes Cancer; 2009 Feb; 48(2):184-93. PubMed ID: 18973136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic findings in colorectal cancer mirror multistep evolution of colorectal cancer.
    Pirc-Danoewinata H; Bull JP; Okamoto I; Karner J; Breiteneder S; Liebhardt A; Budinsky A; Marosi C
    Wien Klin Wochenschr; 1996 Dec; 108(23):752-8. PubMed ID: 8990513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas.
    Kardas I; Mrózek K; Babinska M; Krajka K; Hadaczek P; Lubinski J; Roszkiewicz A; Kuziemska E; Limon J
    Oncol Rep; 2005 May; 13(5):949-56. PubMed ID: 15809763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology.
    Babu VR; Lutz MD; Miles BJ; Farah RN; Weiss L; Van Dyke DL
    Cancer Res; 1987 Dec; 47(24 Pt 1):6800-5. PubMed ID: 3479251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consistent occurrence of a 19p+ marker chromosome and loss of 11p material in ovarian seropapillary cystadenocarcinomas.
    Pejovic T; Heim S; Mandahl N; Elmfors B; Flodérus UM; Furgyik S; Helm G; Willén H; Mitelman F
    Genes Chromosomes Cancer; 1989 Nov; 1(2):167-71. PubMed ID: 2487157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Karyotypic characterization of colorectal adenocarcinomas.
    Bardi G; Sukhikh T; Pandis N; Fenger C; Kronborg O; Heim S
    Genes Chromosomes Cancer; 1995 Feb; 12(2):97-109. PubMed ID: 7535093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group.
    Mertens F; Dal Cin P; De Wever I; Fletcher CD; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; van Den Berghe H; Vanni R; Willén H
    J Pathol; 2000 Jan; 190(1):31-8. PubMed ID: 10640989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas.
    Kovacs G; Frisch S
    Cancer Res; 1989 Feb; 49(3):651-9. PubMed ID: 2910484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic studies of prostatic cancer.
    Lundgren R
    Scand J Urol Nephrol Suppl; 1991; 136():1-35. PubMed ID: 1871551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal abnormalities of adenocarcinoma of the pancreas: identifying early and late changes.
    Kowalski J; Morsberger LA; Blackford A; Hawkins A; Yeo CJ; Hruban RH; Griffin CA
    Cancer Genet Cytogenet; 2007 Oct; 178(1):26-35. PubMed ID: 17889705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 12 breakpoints are cytogenetically different in benign and malignant lipogenic tumors: localization of breakpoints in lipoma to 12q15 and in myxoid liposarcoma to 12q13.3.
    Mrózek K; Karakousis CP; Bloomfield CD
    Cancer Res; 1993 Apr; 53(7):1670-5. PubMed ID: 8453640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonrandom chromosome changes in malignant melanoma.
    Becher R; Gibas Z; Karakousis C; Sandberg AA
    Cancer Res; 1983 Oct; 43(10):5010-6. PubMed ID: 6883347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas.
    Bayani J; Zielenska M; Pandita A; Al-Romaih K; Karaskova J; Harrison K; Bridge JA; Sorensen P; Thorner P; Squire JA
    Genes Chromosomes Cancer; 2003 Jan; 36(1):7-16. PubMed ID: 12461745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome abnormalities in human non-small cell lung cancer.
    Testa JR; Siegfried JM
    Cancer Res; 1992 May; 52(9 Suppl):2702s-2706s. PubMed ID: 1314134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetics of multiple myeloma.
    Trcić RL; Skelin IK; Sustercić D; Planinc-Peraica A; Ajduković R; Haris V; Kusec R; Begović D
    Coll Antropol; 2010 Mar; 34(1):41-4. PubMed ID: 20432732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.